ACRS   $5.5  1.85% Market Closed After Close 5.41 -1.64%

Aclaris Therapeutics, Inc.

EMA (20): 2026-09-09 the price crossed down the moving average line and demonstrates a downside trend.

EMA (50): 2026-09-09 the price crossed down the moving average line and trying to form a short-term downside trend.

EMA (100): 2026-03-02 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

Trend Type linear up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -2.88%
EMA (20) date of signal Sept. 9, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -2.88%
EMA (50) date of signal Sept. 9, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 77.05%
EMA (100) date of signal March 2, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 17, 2026, 3 a.m.
MACD Signals bearish
MACD Yield 0.0
MACD date of signal Sept. 17, 2026, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield -4.26%
Stochastic date of signal Sept. 14, 2026, 3 a.m.
Updated Sept. 18, 2026, 11 p.m.